Cargando…
Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning
Improving productivity to reduce the cost of biologics manufacturing and ensure that therapeutics can reach more patients remains a major challenge faced by the biopharmaceutical industry. Chinese hamster ovary (CHO) cell lines are commonly prepared for biomanufacturing by single cell cloning post-t...
Autores principales: | He, Qin, Rehmann, Matthew S., Tian, Jun, Xu, Jianlin, Sabino, Luzmary, Vandermark, Erik, Basson, Ziev, Po, Iris, Bierilo, Kathleen, Tremml, Gabi, Rizzi, Giovanni, Langsdorf, Erik F., Qian, Nan-Xin, Borys, Michael C., Khetan, Anurag, Li, Zheng-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030702/ https://www.ncbi.nlm.nih.gov/pubmed/35447733 http://dx.doi.org/10.3390/bioengineering9040173 |
Ejemplares similares
-
Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studies
por: Bolisetty, Parimala, et al.
Publicado: (2020) -
Metabolomic and quality data for early and late passages of an antibody-producing industrial CHO cell line
por: Sowa, Steven W., et al.
Publicado: (2020) -
N-1 Perfusion Platform Development Using a Capacitance Probe for Biomanufacturing
por: Rittershaus, Emily S. C., et al.
Publicado: (2022) -
Upstream cell culture process characterization and in-process control strategy development at pandemic speed
por: Xu, Jianlin, et al.
Publicado: (2022) -
High throughput screening data for a case study of CHO cell culture process development
por: He, Qin, et al.
Publicado: (2021)